We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,107 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8844,107 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,107
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.06%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
WOC
501
West Oak Capital
California
$23.2M +$35.6K +230 +1%
EPIM
502
Evelyn Partners Investment Management
$23.1M +$24.8M +159,902 New
TCOV
503
Trust Company of Vermont
Vermont
$23.1M -$77.5K -500 -0.3%
Wealthfront Advisers
504
Wealthfront Advisers
California
$23M +$2.26M +14,614 +10%
TRCT
505
Tower Research Capital (TRC)
New York
$23M +$10.2M +66,143 +71%
CCM
506
Coerente Capital Management
Ontario, Canada
$22.9M +$310K +1,998 +1%
CFG
507
Citizens Financial Group
Rhode Island
$22.8M -$2.62M -16,883 -10%
SYBT
508
Stock Yards Bank & Trust
Kentucky
$22.6M -$16M -103,330 -40%
DJSG
509
D.J. St. Germain
Massachusetts
$22.5M -$145K -937 -0.6%
CVM
510
Cheviot Value Management
California
$22.5M +$2.14M +13,823 +10%
Capstone Investment Advisors
511
Capstone Investment Advisors
New York
$22.4M +$21.5M +138,621 +846%
IC
512
IEQ Capital
California
$22.4M +$1.38M +8,882 +6%
ECG
513
Edge Capital Group
Georgia
$22.3M -$20.2M -130,220 -100%
ABC
514
Associated Banc-Corp
Wisconsin
$22.3M -$1.34M -8,676 -5%
VHAM
515
Van Hulzen Asset Management
California
$22.2M +$280K +1,807 +1%
GT
516
Glenview Trust
Kentucky
$22.2M -$621K -4,006 -3%
VI
517
Vestcor Inc
New Brunswick, Canada
$22M -$632K -4,077 -3%
BCM
518
Bridgeway Capital Management
Texas
$21.9M +$70.4K +454 +0.3%
FNT
519
First National Trust
Pennsylvania
$21.8M +$79.2K +511 +0.3%
HF
520
HRT Financial
New York
$21.8M -$1.26M -8,125 -5%
ESBC
521
E.S. Barr & Co
Kentucky
$21.8M -$1.35M -8,686 -5%
ACM
522
Ardent Capital Management
Ohio
$21.7M +$480K +3,096 +2%
WB
523
WesBanco Bank
West Virginia
$21.7M -$527K -3,402 -2%
AAF
524
Andra AP-fonden
Sweden
$21.7M -$37.2M -240,300 -62%
HI
525
Hendershot Investments
Virginia
$21.7M +$485K +3,131 +2%

JNJ Hedge Fund Activity: Q4 2024 in Review

4,107 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,107 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,884 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.